Abstract
The rheumatoid arthritis drugs, tocilizumab and sarilumab, should be considered in the treatment of COVID-19 patients admitted to intensive care, according to updated NHS guidance. The new advice, which is due to be published on 8 January 2020, follows results released from the Randomised, Embedded, Multi-factorial, Adaptive Platform Trial for Community-Acquired pneumonia (REMAP-CAP), which suggested […]
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call